Published in AIDS Weekly, November 29th, 2004
"These data help demonstrate the versatility of TRIZIVIR as a treatment for HIV in different clinical situations, and illustrate GSK's ongoing commitment to simplify HIV treatment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.